Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentBeginning Cash BalanceCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Rockwell Medical (RMTI) Other financing activities: 2012-2023

  • Rockwell Medical's Other financing activities was N/A to -$38,000 in Q4 2023 from the same period last year, while for Dec 2023 it was $1.3 million, marking a year-over-year change of. This contributed to the annual value of $5,000 for FY2023, which is 95.28% down from last year.
  • Rockwell Medical's Other financing activities amounted to -$38,000 in Q4 2023, which was down 188.37% from $43,000 recorded in Q3 2023.
  • In the past 5 years, Rockwell Medical's Other financing activities ranged from a high of $969,000 in Q2 2020 and a low of -$38,000 during Q4 2023.
  • In the last 1 years, Rockwell Medical's Other financing activities had a median value of $2,500 in 2023 and averaged $2,500.